Why the study?
Few studies have validated and standardized echocardiographic parameters to diagnose pulmonary hypertension and right ventricular hypertrophy in experimental animal models.
What are the optimal echocardiographic cut-off values to diagnose pulmonary hypertension in rat models compared to invasive hemodynamics?
What are the optimal echocardiographic cut-off values to diagnose pulmonary hypertension in rat models compared to invasive hemodynamics?
Validated echocardiographic cut-offs (PAAT/ET ≤0.25 or RV wall thickness ≥1.03 mm) accurately predict invasive pulmonary hypertension in rat models, enabling non-invasive monitoring in preclinical studies.
These cut-offs may streamline non-invasive monitoring in rat PH models; leaves open human translation.
Echocardiography is the gold standard non‐invasive technique to diagnose pulmonary hypertension. It is also an important modality used to monitor disease progression and response to treatment in patients with pulmonary hypertension. Surprisingly, only few studies have been conducted to validate and standardize echocardiographic parameters in experimental animal models of pulmonary hypertension. We sought to define cut‐off values for both invasive and non‐invasive measures of pulmonary hemodynamics and right ventricular hypertrophy that would reliably diagnose pulmonary hypertension in three different rat models. The study was designed in two phases: (1) a derivation phase to establish the cut‐off values for invasive measures of right ventricular systolic pressure, Fulton's index (right ventricular weight/left ventricle + septum weight), right ventricular to body weight ratio, and non‐invasive echocardiographic measures of pulmonary arterial acceleration time, pulmonary arterial acceleration time to ejection time ratio and right ventricular wall thickness in diastole in the hypoxic and monocrotaline rat models of pulmonary hypertension and (2) a validation phase to test the performance of the cut‐off values in predicting pulmonary hypertension in an independent cohort of rats with Sugen/hypoxia‐induced pulmonary hypertension. Our study demonstrates that right ventricular systolic pressure ≥35.5 mmHg and Fulton's Index ≥0.34 are highly sensitive (>94%) and specific (>91%) cut‐offs to distinguish animals with pulmonary hypertension from controls. When pulmonary arterial acceleration time/ejection time and right ventricular wall thickness in diastole were both measured, a result of either pulmonary arterial acceleration time/ejection time ≤0.25 or right ventricular wall thickness in diastole ≥1.03 mm detected right ventricular systolic pressure ≥35.5 mmHg or Fulton's Index ≥0.34 with a sensitivity of 88% and specificity of 100%. With properly validated non‐invasive echocardiography measures of right ventricular performance in rats that accurately predict invasive measures of pulmonary hemodynamics, future studies can now utilize these markers to test the efficacy of different treatments with preclinical therapeutic modeling.
No takes yet. Share an insight, caveat, or question.
Spyropoulos et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: